Bone Drug May Help Fight Breast Cancer As Part Of Therapy Researchers from Austria and Germany found that adding the bone drug zoledronic acid to endocrine therapy improved disease-free survival in premenopausal women with early stage breast cancer of the estrogen-responsive type.
Source: www.medicalnewstoday.comPublic Cancer Center Becomes First In South-East Asia To Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems Doctors in Hong Kong have carried out the first treatments in south-east Asia using a new, faster form of radiotherapy that extends more advanced care to more patients. A 74-year- old patient with localized prostate cancer became the region's first patient to receive treatment using RapidArc radiotherapy technology from Varian Medical Systems .
Source: www.medicalnewstoday.comGuideline For Treating Chronic Non-Cancer Pain With Opioid Medications A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain. The long-awaited guideline appears in the current issue of The Journal of Pain, http://www.jpain.
Source: www.medicalnewstoday.comEnzyme Design Dramatically Speeded Up By Duke Software A Duke University-led team has brought powerful software to the never-ending arms race between antibiotics and germs. Working together, computer scientists and biochemists have developed and laboratory-tested a computer program that can show experimentalists how to change the machinery that bacteria use to make
natural antibiotics.
Source: www.medicalnewstoday.comSt. Jude Medical Welcomes Introduction Of Legislation To Help People Suffering From Pain St. Jude Medical, Inc. (NYSE:STJ) welcomes the introduction of the National Pain Care Policy Act of 2009, H.R. 756. Intended to raise awareness about the growing issue of pain, this legislation is focused on improving access to patient care in the United States. Led by U.S.
Source: www.medicalnewstoday.comThermaFreeze Successfully Completes FDA Compliance Testing With Intertek For Consumer Use Of ThermaFreeze(R) Ice Pads Red Bank, NJ-based ThermaFreeze Products Corporation (PINKSHEETS: TFZP) today announced the completion of
FDA compliance testing on its ThermaFreeze® ice pads used to keep foods and beverages cool in variety of consumer applications.
Source: www.medicalnewstoday.comForcing Evolution: Boosting Its Infectivity Turns Benign Virus Into Good Gene Therapy Carrier For Cystic Fibrosis Researchers from the University of California, Berkeley, and the University of Iowa have turned a relatively benign virus into a highly infectious form that is ideal as a carrier for gene therapy. In its first gene therapy test, it completely cured human cystic fibrosis lung tissue in culture.
Source: www.medicalnewstoday.comSylvester Researcher Uncovers Potential Therapeutic Target For Prostate Cancer A new discovery by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine points the way to critically important treatment possibilities for patients with advanced prostate cancer in whom chemotherapy and hormone therapy have failed.
Source: www.medicalnewstoday.comSanofi Pasteur Starts A Phase II Study Of A Vaccine Against Clostridium Difficile Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN et NYSE : SNY), announced today that it is sponsoring a phase II clinical study of a vaccine against Clostridium difficile, which is among the most common causes of hospital-acquired infection in Europe and North America.
Source: www.medicalnewstoday.com
# posted by Network @ 1:00 PM
